TransFACT predicts embryo viability using day-4 time-lapse video analysis
Transformer framework predicts bovine embryo transferability three days earlier than current methods.
Current bovine embryo transfer practice relies on a single expert assessment on day seven post-insemination, leading to high rates of pregnancy loss. Time-lapse videomicroscopy captures detailed early development but is difficult to exploit due to complex motion patterns and time-consuming analysis. To address this, researchers introduce TransFACT, a transformer-based framework that models early developmental stages from 2D time-lapse videos over the first four days. It combines frame-level temporal features with stage-level representations, using developmental stages as auxiliary supervision to predict transferability on day four. The model leverages an existing action recognition method, achieving superior performance over competitors in predicting embryo transferability.
TransFACT's ability to assess embryo viability three days earlier than standard practice could significantly reduce pregnancy losses and improve breeding efficiency in cattle. The technique also shows potential for adaptation to other species, including human IVF, where early, non-invasive prediction of embryo quality remains a major challenge. By automating the analysis of time-lapse microscopy, TransFACT offers a scalable, objective tool for embryologists, moving from subjective day-seven snapshots to data-driven, temporal decisions. The paper is accepted at ICIP 2026 (Tampere, Finland) and available on arXiv.
- TransFACT predicts bovine embryo transferability on day 4 using only the first four days of time-lapse video.
- Combines frame-level temporal features with stage-level representations, using developmental stages as auxiliary supervision.
- Outperforms existing methods by leveraging action recognition techniques; accepted at ICIP 2026.
Why It Matters
Earlier, automated embryo selection could cut pregnancy losses and boost efficiency in cattle breeding—and potentially human IVF.